BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Business

  HitGen Announces Drug Discovery Collaboration With The Scripps Research Institute And The California Institute For Biomedical Research (Calibr)

  April 24, 2017

   · 

  2 min read
• Drug Development

  Tiziana Life Sciences Plc Announces Approval Of A Phase II Clinical Trial Protocol For Milciclib In Patients With Hepatocellular Carcinoma

  April 24, 2017

   · 

  5 min read
• Drug Development

  ReViral Announces Good Safety And Pharmacokinetics From Phase I Programme For RSV Antiviral RV521 In Healthy Volunteers

  April 24, 2017

   · 

  4 min read
• FDA

  Samsung Bioepis Obtains First Drug Approval In The United States, As FDA Approves RENFLEXIS (Infliximab-Abda) Across All Eligible Indications

  April 24, 2017

   · 

  12 min read
• Business

  First-Quarter Figures: Sartorius Corporation Starts Off 2017 With Double-Digit Growth

  April 24, 2017

   · 

  1 min read
• Drug Development

  Paragonix Technologies Inc. Announces Presentation Of The Sherpapak Organ Transport Systems At American Transplant Congress (Chicago, April 29 - May 3, 2017)

  April 24, 2017

   · 

  6 min read
• FDA

  Sanofi Receives FDA Approval Of Thymoglobulin For The Prevention Of Acute Kidney Transplant Rejection

  April 24, 2017

   · 

  9 min read
• Drug Development

  NGM Announces NGM282 Dramatically Reduced Liver Fat And Other Biomarkers Associated With Nonalcoholic Steatohepatitis (NASH) In Phase II Trial

  April 24, 2017

   · 

  7 min read
• Drug Development

  American Regent, Inc. Announces Enrollment Of First Patient In Phase III Trial To Investigate Injectafer (Ferric Carboxymaltose) As Treatment For Heart Failure With Iron Deficiency

  April 24, 2017

   · 

  7 min read
• Drug Development

  DURECT Announces Presentation Of Data From A Phase Ib Study Of DUR-928 In Nonalcoholic Steatohepatitis (NASH) At The International Liver Congress 2017

  April 24, 2017

   · 

  6 min read